EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Heterozygous CECR2 variants support a distinct neurodevelopmental syndrome with features overlapping cat eye syndrome

Anushree Acharya, Irma Järvelä, Andrea Hernandez, Yasmin Rajendran, Thashi Bharadwaj, Dana H Goodloe, Susan M Hiatt, Jennifer Morrison, Patricia G Wheeler, Jesse M Hunter, Rachel Supinger, Scott E Hickey und 8 weitere

Human Genetics and Genomics Advances · 2026

DOI: 10.1016/j.xhgg.2026.100613 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Genetics and Genomics Advances, 2026. Verfasst von Anushree Acharya und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Neurosciences, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA. Hauptthemen laut MEDLINE: Chromosome Disorders, Corneal Opacity, Mutation, Neurodevelopmental Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, National Institute of Child Health and Human Development, National Institute on Deafness and Other Communication Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The CECR2 histone acetyl-lysine reader facilitates chromatin remodeling and plays a significant role in neurodevelopment. It resides within the cat eye syndrome (CES) critical region at 22q11.1q11.21. An increased copy number of this region, often as tetrasomy or a supernumerary chromosome, results in CES. The complex chromosomal arrangements and phenotypic variability have hampered the identification of the true cause(s) of CES. Patients and their clinical data were collected from multiple diagnostic and research laboratories. Exome or genome sequencing was performed in affected individuals and, when available, their relatives. Here, we describe six patients with a heterozygous single-nucleotide or small insertion/deletion variant in CECR2 and their clinical features. Variants were either loss-of-function [c.1734dupC:p.(Thr580Hisfs∗98), c.1819C>T:p.(Arg607∗), and c.2281C>T:p.(Arg761∗)] or missense in an intrinsically disordered and potentially critical region at the C terminus of the protein [c.4153C>G:p.(Gln1385Glu), c.4254C>G:p.(Phe1418Leu), and c.4283A>G:p.(Gln1428Arg)]. The main clinical features were delayed growth, relatively small head circumference, developmental delay, and speech issues/delay. Other clinical findings were variable and included intellectual disability; feeding problems; facial dysmorphism; cleft lip/palate; brain, ear, heart, or other organ abnormalities; behavioral abnormalities; and epilepsy. There was significant overlap with common CES features, including ear, heart, and brain abnormalities, intellectual disability, and growth restriction. In conclusion, we characterize a CECR2-associated neurodevelopmental disorder. The consistent molecular and clinical overlap with CES supports CECR2's role in the CES phenotype. These findings implicate diverse variant types in related neurodevelopmental disorders, underscoring CECR2's dosage sensitivity and essential function in epigenetic regulation during development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromosome DisordersCorneal OpacityMutationNeurodevelopmental DisordersChildChild, PreschoolFemaleHumansInfantMaleHeterozygotePhenotypeAneuploidyChromosomes, Human, Pair 22Eye Abnormalities

Stichwörter der Autor:innen

22q11.1q11.21cat eye syndromececr2dosage sensitivityneurodevelopmentvariant

Autor:innen und Institutionen

  • Department of Translational Neurosciences, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA.
  • Department of Medical Genetics, University of Helsinki, Helsinki, Finland.
  • Center for Statistical Genetics, Gertrude H. Sergievsky Center and the Department of Neurology, Columbia University Medical Center, New York, NY, USA.
  • Department of Genetics, the University of Alabama at Birmingham, Birmingham, AL 35223, USA.
  • HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
  • Arnold Palmer Hospital for Children, Orlando Health Orlando Regional Medical Center, Orlando, FL, USA.

Förderung

  • NICHD NIH HHS
  • National Institute of Child Health and Human Development
  • National Institute on Deafness and Other Communication Disorders

Zitieren

APA

Acharya, A., Järvelä, I., Hernandez, A., Rajendran, Y., Bharadwaj, T., Goodloe, D. H., Hiatt, S. M., Morrison, J., Wheeler, P. G., Hunter, J. M., Supinger, R., Hickey, S. E., Petersen, A. K., Magnussen, K., Scala, M., Striano, P., Zara, F., Leppälä, J., Leal, S. M., & Schrauwen, I. (2026). Heterozygous CECR2 variants support a distinct neurodevelopmental syndrome with features overlapping cat eye syndrome. Human Genetics and Genomics Advances. https://doi.org/10.1016/j.xhgg.2026.100613

Vancouver

Acharya A, Järvelä I, Hernandez A, Rajendran Y, Bharadwaj T, Goodloe DH, et al. Heterozygous CECR2 variants support a distinct neurodevelopmental syndrome with features overlapping cat eye syndrome. Human Genetics and Genomics Advances. 2026. doi:10.1016/j.xhgg.2026.100613

BibTeX
@article{Acharya2026,
  author = {Acharya, Anushree and Järvelä, Irma and Hernandez, Andrea and Rajendran, Yasmin and Bharadwaj, Thashi and Goodloe, Dana H and Hiatt, Susan M and Morrison, Jennifer and Wheeler, Patricia G and Hunter, Jesse M and Supinger, Rachel and Hickey, Scott E and Petersen, Andrea K and Magnussen, Kari and Scala, Marcello and Striano, Pasquale and Zara, Federico and Leppälä, Juha and Leal, Suzanne M and Schrauwen, Isabelle},
  title = {Heterozygous CECR2 variants support a distinct neurodevelopmental syndrome with features overlapping cat eye syndrome},
  journal = {Human Genetics and Genomics Advances},
  year = {2026},
  doi = {10.1016/j.xhgg.2026.100613}
}
Kostenlos starten →